• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Wednesday, August 27, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

Japan Starts Vaccination For Children Aged 6 Months To 4 Years

by Agency Report
3 years ago
in News
Japan Starts Vaccination For Children
Share on WhatsAppShare on FacebookShare on XTelegram

Japan on Tuesday began coronavirus vaccinations for children aged six months to four years at a hospital in Tokyo, expanding the eligibility criteria for inoculation to almost all age groups.

Advertisement

Vaccinations for babies and young children in other areas of the country are set to follow as soon as local governments are ready, since deliveries of the vaccine began the previous day.

Children will be required to have a total of three doses of the vaccine, which targets the original strain discovered in Wuhan, China, in 2019, in order to achieve a similar level of immunity as those in other age groups.

The first and second shots must be administered three weeks apart, while the third inoculation will be given at least eight weeks after the second shot.

Inoculation can be carried out at the same time as the influenza vaccine, but no other vaccines can be administered, in principle, for two weeks before and after vaccination.

RELATED

As Respite Returns To Katsina, Residents Laud Gov Radda’s Watch Corps

Gov Radda Cuts Leave Short To Visit Community Attacked By Bandits In Katsina

57 seconds ago
Ex-Presidential Candidate Tasks Councils On Safe Shuttle Buses

2027: FCT PDP Stakeholders Reject Zoning To South, Endorse Olawepo-Hashim

7 minutes ago
ADVERTISEMENT

Although the vaccine, produced by Pfizer Inc. and BioNTech SE, was not specifically developed to combat the highly contagious Omicron variant, clinical trials have shown the vaccine to be effective, with an efficacy of around 73 percent.

Clinical trials also found that 16 percent of children between 6 months and less than 2 years old reported arm pain, while 7 percent in the same age group experienced fever after inoculation.

Among children aged between 2 and 4 years, 27 percent experienced arm pain and 25 percent reported fatigue, but Japan’s health ministry said most of the side effects were mild and there were no safety issues.

ADVERTISEMENT

At a hospital in Tokyo’s Minato Ward, 2-year-old Yui Iwami received the shot on the lap of her mother, Yumiko, who said she was concerned about the “eighth wave” of the coronavirus infections, which is thought likely to spread around the same time as the seasonal flu.

“I made sure my daughter received the shot to prevent her from getting seriously ill. I came on the first day because I was looking forward to getting her vaccinated,” the 36-year-old mother said.

All of the 20 reservations for the shots on the day were filled, according to the local government.

Inoculation for younger children started after an increase in the number of children who died or suffered severe symptoms, as the spread of the Omicron variant led to a sharp rise in infections.

An academic report has shown that around 60 percent of children who developed moderate or severe symptoms due to infections since July were under the age of 5, according to the Ministry of Health, Labor and Welfare.

 

 


Join Our WhatsApp Channel

Nigerians can now earn US Dollars monthly by acquiring domains cheaply and reselling for profits up to $18,000 (nearly ₦30Million). Beneficiaries include professionals, entrepreneurs, civil servants and more. Click here to start.


SendShare10172Tweet6358Share
ADVERTISEMENT
Previous Post

Osun Senatorial Candidate Seeks Youths Inclusion In Governance

Next Post

I‘ll Carry Everyone Along As C/River Gov – Onor

Agency Report

Agency Report

You May Like

As Respite Returns To Katsina, Residents Laud Gov Radda’s Watch Corps
News

Gov Radda Cuts Leave Short To Visit Community Attacked By Bandits In Katsina

2025/08/27
Ex-Presidential Candidate Tasks Councils On Safe Shuttle Buses
News

2027: FCT PDP Stakeholders Reject Zoning To South, Endorse Olawepo-Hashim

2025/08/27
Imo Descending To A Failed State, Says Ihedioha
News

Okigwe Killings Represent Governance Failure – Ihedioha

2025/08/27
Nigeria’ll Rise On Tech, Food Security — Tinubu
News

Nigeria’ll Rise On Tech, Food Security — Tinubu

2025/08/27
2023 Polls: Blame INEC, Not Atiku, Aide Replies Adeyanju
News

Oyo APC Tasks INEC On Hitch-free Voter Registration Exercise

2025/08/27
NECO To Conduct SSCE In Saudi Arabia
News

NECO Denounces Fake Recruitment Notice

2025/08/27
Leadership Conference advertisement

LATEST

Gov Radda Cuts Leave Short To Visit Community Attacked By Bandits In Katsina

2027: FCT PDP Stakeholders Reject Zoning To South, Endorse Olawepo-Hashim

Okigwe Killings Represent Governance Failure – Ihedioha

Nigeria’ll Rise On Tech, Food Security — Tinubu

Oyo APC Tasks INEC On Hitch-free Voter Registration Exercise

Security Agents Arrest 2 Suspected Vandals In Akwa Ibom

NECO Denounces Fake Recruitment Notice

Crystal Palace Approach Man City For Akanji

Kwara Varsity Lecturers Stage Peaceful Protest, Demand Payment Of EAA, Others

Crystal Palace Agree £26m Deal For Villarreal Winger Pino

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.